About Calando Pharmaceuticals
Calando Pharmaceuticals was a Healthcare company based in Pasadena (United States) founded in 2005. It develops innovative siRNA-based therapeutics and nanoparticle-drug conjugates for cancer. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Pharmaceuticals and Cancer Therapeutics. Similar companies include Alnylam, C4 Therapeutics and Erasca; 3 of its 3 listed similar companies have raised funding.
Company details
Calando Pharmaceuticals, established in 2005 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and cancer therapeutics. Develops innovative siRNA-based therapeutics and nanoparticle-drug conjugates for cancer. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Pasadena, United States
- SectorsHealthcare
- Website calandopharma.com
Similar companies to Calando Pharmaceuticals
Calando Pharmaceuticals has 3 listed similar companies in our database, 3 of them funded. They include Alnylam, C4 Therapeutics and Erasca.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. | |
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. |
Detailed similar companies of Calando Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Calando Pharmaceuticals
Websites that share an audience with Calando Pharmaceuticals (calandopharma.com).
Websites whose visitors overlap most with Calando Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| santaris.com | 99% | View details | |||
| sylentis.com | 87% | 3.9K | #4,931,838 | View details | |
| alnylam.com | 74% | 77.8K | #414,009 | View details |
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Calando Pharmaceuticals (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Calando Pharmaceuticals
Calando Pharmaceuticals was founded in 2005.
Calando Pharmaceuticals is headquartered in Pasadena, United States. It is registered at Pasadena, California, United States.
Calando Pharmaceuticals, established in 2005 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and cancer therapeutics. Develops innovative siRNA-based therapeutics and nanoparticle-drug conjugates for cancer. Adapting to market demands with innovation and client-focused strategies.
Calando Pharmaceuticals's top competitors include C4 Therapeutics, Erasca and Alnylam.